Healthy free cash flow has enabled Johnson & Johnson (JNJ) to increase its dividend over the past half century, notes Lee Bohl. He and Damien Conover discuss takeaways from JNJ earnings. JNJ's 1Q worldwide pharmaceutical sales came in at $13.41B and its 1Q revenue came in at $24.75B versus an estimated $23.57B. They also go over other stocks to keep on your radar. Tune in to find out more about the stock market today.
18 Apr 2023
Market On Close
08 May 2023
Next Gen Investing
18 Apr 2023
Trading 360
09 Mar 2023
Morning Trade Live
10 May 2023
Trading 360
25 May 2023
Futures
06 Apr 2023